Chawla, S. P., Razak, A., Hu, J. S., Singh, A. S., Leu, K., Liebner, D. A., Mehren, M. V., Pink, D., Terés, R., Valverde, C., Riedel, R. F., Guedes, K., Schwartz, B., Gordon, E. M., Bender, L. H., Meyer, C. (2025). A multicenter, randomized, global phase 3 study to assess the efficacy and safety of intratumoral (IT) INT230-6 (SHAO, vinblastine, cisplatin) as monotherapy compared with standard of care systemic chemotherapy in adults with locally recurrent, inoperable, or metastatic soft tissue sarcomas (STS; INVINCIBLE-3).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps11588